MEASLES VIRUS: THE VIRION AND ITS REPLICATIVE STRATEGY
Project Number5R01AI020532-03
Contact PI/Project LeaderUDEM, STEPHEN A.
Awardee OrganizationALBERT EINSTEIN COLLEGE OF MEDICINE
Description
Abstract Text
This research proposal seeks to rigorously characterize the molecular
biology of the acute measles virus infectious cycle, and of its progeny -
the completed, infectious measles virion. Establishing the details of
measles virus replication during acute, productive infection is
prerequisite to the long-range goals of my laboratory's research program -
those being the identification of the mechanism(s) by which persistent
measles infections are established and maintained, and the assessment of
the role played by such infection in the pathogenesis of chronic human
disease.
On the basis of our previous studies, we have selected the HeLa tissue
culture suspension cell as the laboratory 'model' for the examination of
the replicative strategy by which progeny virus are generated during acute,
productive infection. Using methods and probes already developed, the
synthesis and structure of the virus-specified macromolecules will be
analyzed, and their role(s) in the reproduction of the infectious virion
established. Particular attention will be given to as yet undefined
features of measles virus and of its acute infectious cycle, including:
(1) the pathways of viral structural protein synthesis, processing,
assembly, and release as infectious progeny; (2) the transcription of viral
mRNAs and the definition of the translation product each encodes; (3)
genome replication; and (4) assessment of the possibility that
non-structural information is encoded by the measles genome.
Furthermore, the clarification of several of the above features of measles
virus reproduction would be best addressed using highly simplified,
well-defined, and easily manipulable in vitro systems. We, therefore, plan
to pursue the development of in vitro transcription (and perhaps in vitro
replication) system(s) with which to examine these virus-specified
synthetic processes when removed from host-cell influences.
National Institute of Allergy and Infectious Diseases
CFDA Code
DUNS Number
110521739
UEI
Project Start Date
01-December-1984
Project End Date
30-June-1988
Budget Start Date
01-December-1986
Budget End Date
30-June-1988
Project Funding Information for 1987
Total Funding
$217,301
Direct Costs
$115,894
Indirect Costs
$101,407
Year
Funding IC
FY Total Cost by IC
1987
National Institute of Allergy and Infectious Diseases
$217,301
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01AI020532-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01AI020532-03
Patents
No Patents information available for 5R01AI020532-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01AI020532-03
Clinical Studies
No Clinical Studies information available for 5R01AI020532-03
News and More
Related News Releases
No news release information available for 5R01AI020532-03
History
No Historical information available for 5R01AI020532-03
Similar Projects
No Similar Projects information available for 5R01AI020532-03